Actuate Therapeutics Inc (ACTU)
NASDAQ: ACTU
· Real-Time Price · USD
6.65
-0.37 (-5.27%)
At close: Sep 25, 2025, 3:59 PM
6.65
0.00%
After-hours: Sep 25, 2025, 04:18 PM EDT
-5.27% (1D)
| Bid | 6.37 |
| Market Cap | 137.94M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -24.68M |
| EPS (ttm) | -3.11 |
| PE Ratio (ttm) | -2.14 |
| Forward PE | -5.38 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 7.45 |
| Volume | 35,980 |
| Avg. Volume (20D) | 105,982 |
| Open | 6.92 |
| Previous Close | 7.02 |
| Day's Range | 6.53 - 7.10 |
| 52-Week Range | 5.47 - 11.99 |
| Beta | 0.15 |
| Ex-Dividend Date | n/a |
About ACTU
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACTU
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACTU stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-19.15%
Actuate Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
2 weeks ago
+7.18%
Actuate Therapeutics shares are trading lower after the company announced an underwritten public offering.